罗斯手术后游离肺动脉自体移植血管瘤的保留瓣膜根部置换术
该研究回顾性分析了1991至2016年间153例接受罗斯手术(游离根部置换技术)的患者,随访25年,重点评估保留瓣膜的再手术。35例(22.9%)因自体移植血管瘤需再手术,其中77%行保留瓣膜根部置换(10例David术、17例Yacoub术),无早期死亡。结论认为David或Yacoub技术可在多数患者中保留自体移植瓣膜,再手术早期死亡率低、中期功能结果良好、再干预率可接受。
要点
- 罗斯术后自体移植血管瘤再手术中,77%可行保留瓣膜根部置换(David或Yacoub术)。
- 保留瓣膜再手术无早期死亡,中期功能结果良好,再干预率可接受。
- 15年免于自体移植瓣膜置换率为92.1%,多数存活患者仍保留肺动脉自体移植瓣膜。
核心结论
- 使用David或Yacoub技术,罗斯术后根部动脉瘤患者中多数可保留自体移植瓣膜。
- 再手术可无早期死亡,中期功能结果良好,再干预率可接受。
研究设计与样本
- 回顾性分析1991年至2016年间在本机构接受罗斯手术(游离根部置换技术)的153例患者(年龄29.6 ± 16.6岁;29.4%为儿童)。
- 随访完整率98.7%,平均随访12.2 ± 5.5年。
主要发现
- 30天死亡率为2.0%。
- 出院时超声心动图显示99.3%的患者无或微量主动脉瓣反流。
- 20年生存概率为85.4%。
- 未发生自体移植心内膜炎病例。
- 自体移植退化率为每患者年2.01%,15年免于自体移植再手术率为75.3%。
临床怎么用
- 作者认为,对于罗斯术后根部动脉瘤患者,使用David或Yacoub技术可在多数患者中保留自体移植瓣膜。
- 作者认为,再手术可无早期死亡,中期功能结果良好,再干预率可接受。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Autograft dilatation is the main long-term complication following the Ross procedure using the freestanding root replacement technique. We reviewed our 25-year experience with the Ross procedure with a special emphasis on valve-sparing reoperations. METHODS: From 1991 to 2016, 153 patients (29.6 ± 16.6 years; 29.4% pediatric) underwent a Ross operation at our institution with implantation of the autograft as freestanding root replacement. The follow-up is 98.7% complete with a mean of 12.2 ± 5.5 years. RESULTS: Mortality at 30-days was 2.0%. Echocardiography documented no or trivial aortic regurgitation in 99.3% of the patients at discharge. Survival probability at 20 years was 85.4%. No case of autograft endocarditis occurred. Autograft deterioration rate was 2.01% per patient-year, and freedom from autograft reoperation was 75.3% at 15 years. A reoperation for autograft aneurysm was required in 35 patients (22.9%) at a mean interval of 11.1 ± 4.6 years after the Ross procedure. A valve-sparing root replacement was performed in 77% of patients, including 10 David and 17 Yacoub procedures with no early mortality. Three patients required prosthetic valve replacement within 2 years after a Yacoub operation. At latest follow-up, 92% of all surviving patients still carry the pulmonary autograft valve. Freedom from autograft valve replacement was 92.1% at 15 years. CONCLUSIONS: Using the David or Yacoub techniques, the autograft valve can be preserved in the majority of patients with root aneurysms after the Ross procedure. Reoperations can be performed with no early mortality, a good functional midterm result, and an acceptable reintervention rate.
引用
- Ratschiller T, Eva SD, Schimetta W, et al. Valve-sparing root replacement for freestanding pulmonary autograft aneurysm after the Ross procedure. J Thorac Cardiovasc Surg. 2018. PMID: 29550073. doi:10.1016/j.jtcvs.2018.01.095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。